Research detection kit AlphaLISA®

IgEserumcell

The AlphaLISA® Human Interleukin 13 Detection Kit is designed for detection and quantitation of human IL-13 in serum, buffered solution or cell culture medium in a homogeneous (no-wash steps, no separation steps) assay. Formats: Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, Features: No-wash steps, no separation steps ELISA alternative technology Sensitive detection Broad sample compatibility Small sample volume Half the time of an ELISA assay Interleukin 13 (IL13) is a 12 kDa cytokine produced by activated Th2 cells and involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. It induces many symptoms of lung allergic disease, including airway hyperresponsiveness, goblet cell metaplasia and mucus hypersecretion, which all contribute to airway obstruction. AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads,